Saba to Delist In US

Mexico’s Grupo Casa Saba plans to delist its US ADS, it says. The pharmaceutical distributor takes into account low trading volumes in the ADS, as well as difficulties that its recent acquisitions have caused in its financial reporting. It intends to request the move from the SEC next week, with the delisting following 10 days from approval. Its shares will continue to be traded on the Mexican Bolsa.